Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.

Osteoarthritis Cartilage

Department of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, Rochester, NY 14642, USA.

Published: January 2008

Objective: To determine the specificity and efficiency of the tamoxifen (TM)-induced Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.

Methods: Col2a1-CreER(T2) transgenic mice were bred with Rosa26 reporter mice. Two-week-old Col2a1-CreER(T2);R26R mice were administered TM for 5 days and were sacrificed 1 and 6 months after TM induction. X-Gal staining was performed.

Results: Efficient Cre-recombination is achieved in adult articular chondrocytes 1 and 6 months after TM induction.

Conclusion: Our findings demonstrate that the Col2a1-CreER(T2) transgenic mouse model is a valuable tool to target genes specifically expressed in articular chondrocytes in a temporally controlled manner in adult mice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271067PMC
http://dx.doi.org/10.1016/j.joca.2007.08.001DOI Listing

Publication Analysis

Top Keywords

articular chondrocytes
16
col2a1-creert2 transgenic
16
cre-recombination articular
8
chondrocytes adult
8
adult col2a1-creert2
8
transgenic mice
8
mice
5
tamoxifen-inducible cre-recombination
4
articular
4
chondrocytes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!